Watchlist

Watchlist
Aratana Therapeutics, Inc. (PETX)
Aratana Therapeutics, Inc. (PETX)
Aratana Therapeutics to Participate at Jefferies 2018 Global Healthcare Conference
LEAWOOD, Kan. , May 22, 2018 /PRNewswire/ --Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, plans on presenting at Jefferies 2018 Global Healthcare Confere…
Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital
LEAWOOD, Kan. , May 21, 2018 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, today announced the Company has appointed Craig Barbarosh and Low…
Engaged Capital updates on portfolio holdings
Activist investor Engaged Capital updates on its holdings at the end of Q1. More news on: Finisar Corporation, Aratana Therapeutics, Apogee Enterprises, Inc., Consumer stocks news, Read more …
Aratana's (PETX) CEO Steven St. Peter on Q1 2018 Results - Earnings Call Transcript
Aratana Therapeutics (PETX) Q1 2018 Results Earnings Conference Call May 4, 2018, 08:30 AM ET Executives Rachel Reiff - Corporate Communications Steven St. Peter - President and CEO Craig Tooman - Chief Financial Officer Analysts John Krieger - William Blair Bruce Jackson…
Aratana Therapeutics beats by $0.01, misses on revenue
Aratana Therapeutics (NASDAQ: PETX ): Q1 EPS of -$0.19 beats by $0.01 . More news on: Aratana Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more …
Aratana Therapeutics Reports First Quarter 2018 Financial Results
LEAWOOD, Kan. , May 3, 2018 /PRNewswire/ --Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, announced its first quarter 2018 financial results. In the first…
Aratana Therapeutics to Report First Quarter 2018 Financial Results
LEAWOOD, Kan. , April 12, 2018 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Friday, May 4, 2018 at 8:30…
Aratana Therapeutics Confirms Receipt of Board Nominations
LEAWOOD, Kan. , April 5, 2018 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, confirmed that it has received a notice of nomination of three dire…
After Hours Gainers / Losers (04/04/2018)
Top gainers: FB +3.4% . INF +1.6% . TWTR +0.9% . More news on: Facebook, Brookfield Global Listed Infrastructure Income Fund, Twitter, Inc., Stocks on the move, , News on ETFs, Read more …
Midday Gainers / Losers (03/27/2018)
Gainers: ASTC +32% . SHOS +31% . NSPR +28% . INNT +15% . TOPS +13% . MBII +13% . PETX +12% . HMNY +12% . ATNX +11% . MYOV +10% . More news on: Astrotech Corporation, Sears Hometown and Outlet Stores, Inc., InspireMD, Inc., , Read more …
Aratana Therapeutics, Inc. (PETX)